Sabra Healthcare REIT
SBRA
359 hedge funds and large institutions have $3.03B invested in Sabra Healthcare REIT in 2023 Q4 according to their latest regulatory filings, with 69 funds opening new positions, 120 increasing their positions, 103 reducing their positions, and 35 closing their positions.
329% more call options, than puts
Call options by funds: $3.75M | Put options by funds: $873K
97% more first-time investments, than exits
New positions opened: 69 | Existing positions closed: 35
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
17% more repeat investments, than reductions
Existing positions increased: 120 | Existing positions reduced: 103
9% more funds holding
Funds holding: 329 → 359 (+30)
2% more capital invested
Capital invested by funds: $2.96B → $3.03B (+$71.2M)
0.04% more ownership
Funds ownership: 91.78% → 91.83% (+0.04%)
Top Buyers
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$48.8M |
| 2 |
Morgan Stanley
New York
|
+$32.6M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$31M |
| 4 |
JAM
Jupiter Asset Management
London,
United Kingdom
|
+$26.4M |
| 5 |
BlackRock
New York
|
+$16.2M |
Top Sellers
| 1 |
JP Morgan Chase
New York
|
-$96.5M |
| 2 |
American Century Companies
Kansas City,
Missouri
|
-$29.2M |
| 3 |
WMSA
Weiss Multi-Strategy Advisers
New York
|
-$23.2M |
| 4 |
GA
GRS Advisors
Chicago,
Illinois
|
-$19.1M |
| 5 |
ACM
Adelante Capital Management
Alameda,
California
|
-$13.6M |
SBRA Hedge Fund Activity: Q4 2023 in Review
359 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Sabra Healthcare REIT (SBRA) for Q4 2023, worth a combined $3.03B — up 2.4% from $2.96B a quarter earlier.
Buyers outnumbered sellers: 69 funds opened new SBRA positions and 35 closed out — a net gain of 34 holders — while 120 added to existing stakes and 103 trimmed.
The largest buyer was Deutsche Bank, adding an estimated $48.8M. The largest seller was JP Morgan Chase, cutting an estimated $96.5M.
- 359 institutional investors held Sabra Healthcare REIT (SBRA) as of Q4 2023, up from 329 in Q3 2023.
- Funds reported $3.03B of Sabra Healthcare REIT stock for Q4 2023, up 2.4% quarter-over-quarter.
- 69 funds opened new Sabra Healthcare REIT positions in Q4 2023 and 35 closed out, a net change of +34 holders.
- The largest Sabra Healthcare REIT buyer in Q4 2023 was Deutsche Bank, an estimated $48.8M added.
- The largest Sabra Healthcare REIT seller in Q4 2023 was JP Morgan Chase, an estimated $96.5M sold.
Based on aggregated 13F filings for Q4 2023.